{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:26:01Z","timestamp":1786987561566,"version":"build-2736575974"},"reference-count":65,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.csbj.2024.09.006","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T09:14:59Z","timestamp":1726737299000},"page":"3391-3406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Discovery, development and optimisation of a novel frog antimicrobial peptide with combined mode of action against drug-resistant bacteria"],"prefix":"10.34133","volume":"23","author":[{"given":"Jingkai","family":"Wang","sequence":"first","affiliation":[{"name":"Natural Drug Discovery Group, School of Pharmacy, Queen\u2019s University Belfast, Belfast BT9 7BL, Northern Ireland, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibo","family":"Hu","sequence":"additional","affiliation":[{"name":"Natural Drug Discovery Group, School of Pharmacy, Queen\u2019s University Belfast, Belfast BT9 7BL, Northern Ireland, UK"},{"name":"China Medical University-The Queen's University of Belfast Joint College, No.77 Puhe Road, Shenyang North New Area, Shenyang 110122, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Pu","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Chen","sequence":"additional","affiliation":[{"name":"Natural Drug Discovery Group, School of Pharmacy, Queen\u2019s University Belfast, Belfast BT9 7BL, Northern Ireland, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbang","family":"Ma","sequence":"additional","affiliation":[{"name":"Natural Drug Discovery Group, School of Pharmacy, Queen\u2019s University Belfast, Belfast BT9 7BL, Northern Ireland, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Jiang","sequence":"additional","affiliation":[{"name":"Natural Drug Discovery Group, School of Pharmacy, Queen\u2019s University Belfast, Belfast BT9 7BL, Northern Ireland, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[{"name":"Natural Drug Discovery Group, School of Pharmacy, Queen\u2019s University Belfast, Belfast BT9 7BL, Northern Ireland, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianbao","family":"Chen","sequence":"additional","affiliation":[{"name":"Natural Drug Discovery Group, School of Pharmacy, Queen\u2019s University Belfast, Belfast BT9 7BL, Northern Ireland, UK"},{"name":"China Medical University-The Queen's University of Belfast Joint College, No.77 Puhe Road, Shenyang North New Area, Shenyang 110122, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Shaw","sequence":"additional","affiliation":[{"name":"Natural Drug Discovery Group, School of Pharmacy, Queen\u2019s University Belfast, Belfast BT9 7BL, Northern Ireland, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Natural Drug Discovery Group, School of Pharmacy, Queen\u2019s University Belfast, Belfast BT9 7BL, Northern Ireland, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[{"name":"Natural Drug Discovery Group, School of Pharmacy, Queen\u2019s University Belfast, Belfast BT9 7BL, Northern Ireland, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray C.J.","year":"2022","unstructured":"Murray C.J., Ikuta K.S., Sharara F., Swetschinski L., Robles Aguilar G., Gray A. et al: Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022; 399.","journal-title":"Lancet"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2023.11.031"},{"key":"e_1_3_4_4_2","article-title":"Antimicrobial peptides: mechanism of action, activity and clinical potential","volume":"8","author":"Zhang Q.Y.","year":"2021","unstructured":"Zhang Q.Y., Yan Z.Bin, Meng Y.M., Hong X.Y., Shao G., Ma J.J. et al: Antimicrobial peptides: mechanism of action, activity and clinical potential. Mil Med Res 2021; 8.","journal-title":"Mil Med Res"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial resistance: a global multifaceted phenomenon","volume":"109","author":"Prestinaci F.","year":"2015","unstructured":"Prestinaci F., Pezzotti P. and Pantosti A.: Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health 2015; 109.","journal-title":"Pathog Glob Health"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","DOI":"10.1080\/07388551.2020.1796576","article-title":"Antimicrobial peptides as therapeutic agents: opportunities and challenges","volume":"40","author":"Mahlapuu M.","year":"2020","unstructured":"Mahlapuu M., Bj\u00f6rn C. and Ekblom J.: Antimicrobial peptides as therapeutic agents: opportunities and challenges. Crit Rev Biotechnol 2020; 40.","journal-title":"Crit Rev Biotechnol"},{"key":"e_1_3_4_7_2","doi-asserted-by":"crossref","DOI":"10.1002\/med.21542","article-title":"Antimicrobial peptides: promising alternatives in the post feeding antibiotic era","volume":"39","author":"Wang J.","year":"2019","unstructured":"Wang J., Dou X., Song J., Lyu Y., Zhu X., Xu L. et al: Antimicrobial peptides: promising alternatives in the post feeding antibiotic era. Med Res Rev 2019; 39.","journal-title":"Med Res Rev"},{"key":"e_1_3_4_8_2","article-title":"The antimicrobial peptide LI14 combats multidrug-resistant bacterial infections","volume":"5","author":"Shi J.","year":"2022","unstructured":"Shi J., Chen C., Wang D., Wang Z. and Liu Y.: The antimicrobial peptide LI14 combats multidrug-resistant bacterial infections. Commun Biol 2022; 5.","journal-title":"Commun Biol"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11101417","article-title":"Antimicrobial peptides\u2014mechanisms of action, antimicrobial effects and clinical applications","volume":"11","author":"Talapko J.","year":"2022","unstructured":"Talapko J., Me\u0161trovi\u0107 T., Juzba\u0161i\u0107 M., Tomas M., Eri\u0107 S., Horvat Aleksijevi\u0107 L. et al: Antimicrobial peptides\u2014mechanisms of action, antimicrobial effects and clinical applications. Antibiotics 2022; 11.","journal-title":"Antibiotics"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165773","article-title":"Design, engineering and discovery of novel \u03b1-helical and \u03b2-boomerang antimicrobial peptides against drug resistant bacteria","volume":"21","author":"Bhattacharjya S.","year":"2020","unstructured":"Bhattacharjya S. and Straus S.K.: Design, engineering and discovery of novel \u03b1-helical and \u03b2-boomerang antimicrobial peptides against drug resistant bacteria. Int J Mol Sci 2020; 21.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_4_11_2","article-title":"Piscidin-1-analogs with double L- and D-lysine residues exhibited different conformations in lipopolysaccharide but comparable anti-endotoxin activities","volume":"7","author":"Kumar A.","year":"2017","unstructured":"Kumar A., Mahajan M., Awasthi B., Tandon A., Harioudh M.K., Shree S. et al: Piscidin-1-analogs with double L- and D-lysine residues exhibited different conformations in lipopolysaccharide but comparable anti-endotoxin activities. Sci Rep 2017; 7.","journal-title":"Sci Rep"},{"key":"e_1_3_4_12_2","article-title":"The potential of frog skin peptides for anti-infective therapies: the case of Esculentin-1a(1-21)NH2","volume":"27","author":"Casciaro B.","year":"2019","unstructured":"Casciaro B., Cappiello F., Loffredo M.R., Ghirga F. and Mangoni M.L.: The potential of frog skin peptides for anti-infective therapies: the case of Esculentin-1a(1-21)NH2. Curr Med Chem 2019; 27.","journal-title":"Curr Med Chem"},{"key":"e_1_3_4_13_2","article-title":"New opportunities and challenges of venom-based and bacteria-derived molecules for anticancer targeted therapy","volume":"80","author":"Ma R.","year":"2022","unstructured":"Ma R. and Kwok H.F.: New opportunities and challenges of venom-based and bacteria-derived molecules for anticancer targeted therapy. Semin Cancer Biol 2022; 80.","journal-title":"Semin Cancer Biol"},{"key":"e_1_3_4_14_2","article-title":"In vitro and MD simulation study to explore physicochemical parameters for antibacterial peptide to become potent anticancer peptide","volume":"16","author":"Ma R.","year":"2020","unstructured":"Ma R., Wong S.W., Ge L., Shaw C., Siu S.W.I. and Kwok H.F.: In vitro and MD simulation study to explore physicochemical parameters for antibacterial peptide to become potent anticancer peptide. Mol Ther Oncolytics 2020; 16.","journal-title":"Mol Ther Oncolytics"},{"key":"e_1_3_4_15_2","article-title":"Modification and synergistic studies of a novel frog antimicrobial peptide against Pseudomonas aeruginosa biofilms","volume":"13","author":"Liu X.","year":"2024","unstructured":"Liu X., Shi D., Cheng S., Chen X., Ma C., Jiang Y. et al: Modification and synergistic studies of a novel frog antimicrobial peptide against Pseudomonas aeruginosa biofilms. Antibiotics 2024; 13.","journal-title":"Antibiotics"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial host defence peptides: functions and clinical potential","volume":"19","author":"Mookherjee N.","year":"2020","unstructured":"Mookherjee N., Anderson M.A., Haagsman H.P. and Davidson D.J.: Antimicrobial host defence peptides: functions and clinical potential. Nat Rev Drug Discov 2020; 19.","journal-title":"Nat Rev Drug Discov"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","DOI":"10.1021\/acsinfecdis.0c00022","article-title":"A noncytotoxic Temporin L analogue with in vivo antibacterial and antiendotoxin activities and a nonmembrane-lytic mode of action","volume":"6","author":"Kumari T.","year":"2020","unstructured":"Kumari T., Verma D.P., Afshan T., Verma N.K., Pant G., Ali M. et al: A noncytotoxic Temporin L analogue with in vivo antibacterial and antiendotoxin activities and a nonmembrane-lytic mode of action. ACS Infect Dis 2020; 6.","journal-title":"ACS Infect Dis"},{"key":"e_1_3_4_18_2","article-title":"A frog-derived antimicrobial peptide as a potential anti-biofilm agent in combating Staphylococcus aureus skin infection","volume":"27","author":"Fei F.","year":"2023","unstructured":"Fei F., Wang T., Jiang Y., Chen X., Ma C., Zhou M. et al: A frog-derived antimicrobial peptide as a potential anti-biofilm agent in combating Staphylococcus aureus skin infection. J Cell Mol Med 2023; 27.","journal-title":"J Cell Mol Med"},{"key":"e_1_3_4_19_2","article-title":"The chemistry and biological activities of peptides from amphibian skin secretions","volume":"115","author":"Xu X.","year":"2015","unstructured":"Xu X. and Lai R.: The chemistry and biological activities of peptides from amphibian skin secretions. Chem Rev 2015; 115.","journal-title":"Chem Rev"},{"key":"e_1_3_4_20_2","article-title":"The diversity and evolution of anuran skin peptides","volume":"63","author":"K\u00f6nig E.","year":"2015","unstructured":"K\u00f6nig E., Bininda-Emonds O.R.P. and Shaw C.: The diversity and evolution of anuran skin peptides. Pept (N Y ) 2015; 63.","journal-title":"Pept (N Y )"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","DOI":"10.2741\/4461","article-title":"Antimicrobial peptides from frog skin: biodiversity and therapeutic promises","volume":"21","author":"Ladram A.","year":"2016","unstructured":"Ladram A. and Nicolas P.: Antimicrobial peptides from frog skin: biodiversity and therapeutic promises. Front Biosci - Landmark 2016; 21.","journal-title":"Front Biosci - Landmark"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4471-6458-6_10","article-title":"An overview of brevinin superfamily: Structure, function and clinical perspectives","volume":"818","author":"Savelyeva A.","year":"2014","unstructured":"Savelyeva A., Ghavami S., Davoodpour P., Asoodeh A. and \u0141os M.J.: An overview of brevinin superfamily: Structure, function and clinical perspectives. Adv Exp Med Biol 2014; 818.","journal-title":"Adv Exp Med Biol"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1102576","article-title":"The first Brevinin-1 antimicrobial peptide with LPS-neutralizing and anti-inflammatory activities in vitro and in vivo","volume":"14","author":"Tian M.","year":"2023","unstructured":"Tian M., Wang K., Liang Y., Chai J., Wu J., Zhang H. et al: The first Brevinin-1 antimicrobial peptide with LPS-neutralizing and anti-inflammatory activities in vitro and in vivo. Front Microbiol 2023; 14.","journal-title":"Front Microbiol"},{"key":"e_1_3_4_24_2","article-title":"Antimicrobial peptide Brevinin-1RL1 from frog skin secretion induces apoptosis and necrosis of tumor cells","volume":"26","author":"Ju X.","year":"2021","unstructured":"Ju X., Fan D., Kong L., Yang Q., Zhu Y., Zhang S. et al: Antimicrobial peptide Brevinin-1RL1 from frog skin secretion induces apoptosis and necrosis of tumor cells. Molecules 2021; 26.","journal-title":"Molecules"},{"key":"e_1_3_4_25_2","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200019","article-title":"Brevinin-1GHD: a novel Hylarana guentheri skin secretion-derived Brevinin-1 type peptide with antimicrobial and anticancer therapeutic potential","volume":"40","author":"Jiang Y.","year":"2020","unstructured":"Jiang Y., Wu Y., Wang T., Chen X., Zhou M., Ma C. et al: Brevinin-1GHD: a novel Hylarana guentheri skin secretion-derived Brevinin-1 type peptide with antimicrobial and anticancer therapeutic potential. Biosci Rep 2020; 40.","journal-title":"Biosci Rep"},{"key":"e_1_3_4_26_2","article-title":"Discovery and analysis of a novel antimicrobial peptide B1AW from the skin secretion of Amolops wuyiensis and improving the membrane-binding affinity through the construction of the lysine-introduced analogue","volume":"21","author":"Qin H.","year":"2023","unstructured":"Qin H., Zuo W., Ge L., Siu S.W.I., Wang L., Chen X. et al: Discovery and analysis of a novel antimicrobial peptide B1AW from the skin secretion of Amolops wuyiensis and improving the membrane-binding affinity through the construction of the lysine-introduced analogue. Comput Struct Biotechnol J 2023; 21.","journal-title":"Comput Struct Biotechnol J"},{"key":"e_1_3_4_27_2","article-title":"Brevinin-1BYa: a naturally occurring peptide from frog skin with broad-spectrum antibacterial and antifungal properties","volume":"27","author":"P\u00e1l T.","year":"2006","unstructured":"P\u00e1l T., Abraham B., Sonnevend \u00c1., Jumaa P. and Conlon J.M.: Brevinin-1BYa: a naturally occurring peptide from frog skin with broad-spectrum antibacterial and antifungal properties. Int J Antimicrob Agents 2006; 27.","journal-title":"Int J Antimicrob Agents"},{"key":"e_1_3_4_28_2","article-title":"Chemically modified and conjugated antimicrobial peptides against superbugs","volume":"50","author":"Li W.","year":"2021","unstructured":"Li W., Separovic F., O\u2019Brien-Simpson N.M. and Wade J.D.: Chemically modified and conjugated antimicrobial peptides against superbugs. Chem Soc Rev 2021; 50.","journal-title":"Chem Soc Rev"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","DOI":"10.1021\/ja1083255","article-title":"Structure, interactions, and antibacterial activities of MSI-594 derived mutant peptide MSI-594F5A in lipopolysaccharide micelles: role of the helical hairpin conformation in outer-membrane permeabilization","volume":"132","author":"Domadia P.N.","year":"2010","unstructured":"Domadia P.N., Bhunia A., Ramamoorthy A. and Bhattacharjya S.: Structure, interactions, and antibacterial activities of MSI-594 derived mutant peptide MSI-594F5A in lipopolysaccharide micelles: role of the helical hairpin conformation in outer-membrane permeabilization. J Am Chem Soc 2010; 132.","journal-title":"J Am Chem Soc"},{"key":"e_1_3_4_30_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2009.07.014","article-title":"Micelle-bound structures and dynamics of the hinge deleted analog of melittin and its diastereomer: Implications in cell selective lysis by d-amino acid containing antimicrobial peptides","volume":"1798","author":"Saravanan R.","year":"2010","unstructured":"Saravanan R., Bhunia A. and Bhattacharjya S.: Micelle-bound structures and dynamics of the hinge deleted analog of melittin and its diastereomer: Implications in cell selective lysis by d-amino acid containing antimicrobial peptides. Biochim Biophys Acta Biomembr 2010; 1798.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12080484","article-title":"Enhanced antimicrobial activity of N-terminal derivatives of a novel Brevinin-1 peptide from the skin secretion of Odorrana schmackeri","volume":"12","author":"Zhou X.","year":"2020","unstructured":"Zhou X., Liu Y., Gao Y., Wang Y., Xia Q., Zhong R. et al: Enhanced antimicrobial activity of N-terminal derivatives of a novel Brevinin-1 peptide from the skin secretion of Odorrana schmackeri. Toxins 2020; 12.","journal-title":"Toxins"},{"key":"e_1_3_4_32_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2006.02.009","article-title":"The Chinese bamboo leaf odorous frog (Rana (Odorrana) versabilis) and North American Rana frogs share the same families of skin antimicrobial peptides","volume":"27","author":"Chen T.","year":"2006","unstructured":"Chen T., Zhou M., Rao P., Walker B. and Shaw C.: The Chinese bamboo leaf odorous frog (Rana (Odorrana) versabilis) and North American Rana frogs share the same families of skin antimicrobial peptides. Peptides 2006; 27.","journal-title":"Peptides"},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","DOI":"10.3390\/biom9060249","article-title":"Bioevaluation of ranatuerin-2Pb from the frog skin secretion of Rana pipiens and its truncated analogues","volume":"9","author":"Zhou X.","year":"2019","unstructured":"Zhou X., Shi D., Zhong R., Ye Z., Ma C., Zhou M. et al: Bioevaluation of ranatuerin-2Pb from the frog skin secretion of Rana pipiens and its truncated analogues. Biomolecules 2019; 9.","journal-title":"Biomolecules"},{"key":"e_1_3_4_34_2","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkw329","article-title":"PEP-FOLD3: faster denovo structure prediction for linear peptides in solution and in complex","volume":"44","author":"Lamiable A.","year":"2016","unstructured":"Lamiable A., Thevenet P., Rey J., Vavrusa M., Derreumaux P. and Tuffery P.: PEP-FOLD3: faster denovo structure prediction for linear peptides in solution and in complex. Nucleic Acids Res 2016; 44.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_4_35_2","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btn392","article-title":"HELIQUEST: A web server to screen sequences with specific \u03b1-helical properties","volume":"24","author":"Gautier R.","year":"2008","unstructured":"Gautier R., Douguet D., Antonny B. and Drin G.: HELIQUEST: A web server to screen sequences with specific \u03b1-helical properties. Bioinformatics 2008; 24.","journal-title":"Bioinformatics"},{"key":"e_1_3_4_36_2","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4219","article-title":"Spatial arrangement of proteins in planar and curved membranes by PPM 3.0","volume":"31","author":"Lomize A.L.","year":"2022","unstructured":"Lomize A.L., Todd S.C. and Pogozheva I.D.: Spatial arrangement of proteins in planar and curved membranes by PPM 3.0. Protein Sci 2022; 31.","journal-title":"Protein Sci"},{"key":"e_1_3_4_37_2","article-title":"The HDOCK server for integrated protein\u2013protein docking","volume":"15","author":"Yan Y.","year":"2020","unstructured":"Yan Y., Tao H., He J. and Huang S.Y.: The HDOCK server for integrated protein\u2013protein docking. Nat Protoc 2020; 15.","journal-title":"Nat Protoc"},{"key":"e_1_3_4_38_2","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA","volume":"49","author":"Adasme M.F.","year":"2021","unstructured":"Adasme M.F., Linnemann K.L., Bolz S.N., Kaiser F., Salentin S., Haupt V.J. et al: PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA. Nucleic Acids Res 2021; 49.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_4_39_2","article-title":"Disulfide bond formation in peptides by dimethyl sulfoxide. scope and applications","volume":"113","author":"Tam J.P.","year":"1991","unstructured":"Tam J.P., Wu C.R., Liu W. and Zhang J.W.: Disulfide bond formation in peptides by dimethyl sulfoxide. scope and applications. J Am Chem Soc 1991; 113.","journal-title":"J Am Chem Soc"},{"key":"e_1_3_4_40_2","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-60327-015-1_36","article-title":"Circular dichroism for the analysis of protein-DNA interactions","volume":"543","author":"Cary P.D.","year":"2009","unstructured":"Cary P.D. and Kneale G.G.: Circular dichroism for the analysis of protein-DNA interactions. Methods Mol Biol 2009; 543.","journal-title":"Methods Mol Biol"},{"key":"e_1_3_4_41_2","article-title":"Circular dichroism for the analysis of protein-DNA interactions","volume":"148","author":"Carpenter M.L.","year":"2001","unstructured":"Carpenter M.L., Oliver A.W. and Kneale G.G.: Circular dichroism for the analysis of protein-DNA interactions. Methods Mol Biol 2001; 148.","journal-title":"Methods Mol Biol"},{"key":"e_1_3_4_42_2","doi-asserted-by":"crossref","DOI":"10.1002\/prot.24168","article-title":"Prediction of protein secondary structure from circular dichroism using theoretically derived spectra","volume":"80","author":"Louis-Jeune C.","year":"2012","unstructured":"Louis-Jeune C., Andrade-Navarro M.A. and Perez-Iratxeta C.: Prediction of protein secondary structure from circular dichroism using theoretically derived spectra. Protein Struct, Funct Bioinform 2012; 80.","journal-title":"Protein Struct, Funct Bioinform"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2022.11.016"},{"key":"e_1_3_4_44_2","article-title":"Aggregation and its influence on the bioactivities of a novel antimicrobial peptide, temporin-pf, and its analogues","volume":"22","author":"Zai Y.","year":"2021","unstructured":"Zai Y., Xi X., Ye Z., Ma C., Zhou M., Chen X. et al: Aggregation and its influence on the bioactivities of a novel antimicrobial peptide, temporin-pf, and its analogues. Int J Mol Sci 2021; 22.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_4_45_2","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics9020085","article-title":"Brevinin-2GHK from sylvirana guentheri and the design of truncated analogs exhibiting the enhancement of antimicrobial activity","volume":"9","author":"Chen G.","year":"2020","unstructured":"Chen G., Miao Y., Ma C., Zhou M., Shi Z., Chen X. et al: Brevinin-2GHK from sylvirana guentheri and the design of truncated analogs exhibiting the enhancement of antimicrobial activity. Antibiotics 2020; 9.","journal-title":"Antibiotics"},{"key":"e_1_3_4_46_2","article-title":"Discovery of novel caeridins from the skin secretion of the Australian White\u2019s Tree Frog, Litoria caerulea","volume":"2018","author":"Li L.","year":"2018","unstructured":"Li L., Wu Q., Wang X., Lu H., Xi X., Zhou M. et al: Discovery of novel caeridins from the skin secretion of the Australian White\u2019s Tree Frog, Litoria caerulea. Int J Genom 2018; 2018.","journal-title":"Int J Genom"},{"key":"e_1_3_4_47_2","article-title":"A novel antimicrobial peptide, Dermaseptin-SS1, with anti-proliferative activity, isolated from the skin secretion of Phyllomedusa tarsius","volume":"28","author":"Ma X.","year":"2023","unstructured":"Ma X., Chen Y., Shu A., Jiang Y., Chen X., Ma C. et al: A novel antimicrobial peptide, Dermaseptin-SS1, with anti-proliferative activity, isolated from the skin secretion of Phyllomedusa tarsius. Molecules 2023; 28.","journal-title":"Molecules"},{"key":"e_1_3_4_48_2","article-title":"Structural and functional assessment of mBjAMP1, an antimicrobial peptide from Branchiostoma japonicum, revealed a novel \u03b1-hairpinin-like scaffold with membrane permeable and DNA binding activity","volume":"61","author":"Nam J.","year":"2018","unstructured":"Nam J., Yun H., Rajasekaran G., Kumar S.D., Kim J.Il, Min H.J. et al: Structural and functional assessment of mBjAMP1, an antimicrobial peptide from Branchiostoma japonicum, revealed a novel \u03b1-hairpinin-like scaffold with membrane permeable and DNA binding activity. J Med Chem 2018; 61.","journal-title":"J Med Chem"},{"key":"e_1_3_4_49_2","doi-asserted-by":"crossref","first-page":"22113","DOI":"10.1021\/acsami.9b04654","article-title":"Highly stabilized \u03b1-Helical coiled coils kill gram-negative bacteria by multicomplementary mechanisms under acidic condition","volume":"11","author":"Lai Z.","year":"2019","unstructured":"Lai Z., Tan P., Zhu Y., Shao C., Shan A. and Li L.: Highly stabilized \u03b1-Helical coiled coils kill gram-negative bacteria by multicomplementary mechanisms under acidic condition. ACS Appl Mater Interfaces 2019; 11: 22113.","journal-title":"ACS Appl Mater Interfaces"},{"key":"e_1_3_4_50_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116508","article-title":"Functional characterisation and modification of a novel Kunitzin peptide for use as an anti-trypsin antimicrobial peptide against drug-resistant Escherichia coli","volume":"229","author":"Wang Z.","year":"2024","unstructured":"Wang Z., Ding W., Shi D., Chen X., Ma C., Jiang Y. et al: Functional characterisation and modification of a novel Kunitzin peptide for use as an anti-trypsin antimicrobial peptide against drug-resistant Escherichia coli. Biochem Pharm 2024; 229: 116508.","journal-title":"Biochem Pharm"},{"key":"e_1_3_4_51_2","article-title":"Mechanism of action of the antimicrobial peptide buforin II: Buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions","volume":"244","author":"Park C.B.","year":"1998","unstructured":"Park C.B., Kim H.S. and Kim S.C.: Mechanism of action of the antimicrobial peptide buforin II: Buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun 1998; 244.","journal-title":"Biochem Biophys Res Commun"},{"key":"e_1_3_4_52_2","article-title":"Progressive design of a Ranatuerin-2 peptide from Amolops wuyiensis: enhancement of bioactivity and in vivo efficacy","volume":"13","author":"Yao A.","year":"2024","unstructured":"Yao A., Liu T., Cai Y., Zhou S., Chen X., Zhou M. et al: Progressive design of a Ranatuerin-2 peptide from Amolops wuyiensis: enhancement of bioactivity and in vivo efficacy. Antibiotics 2024; 13.","journal-title":"Antibiotics"},{"key":"e_1_3_4_53_2","article-title":"Antimicrobial peptides\u00b4 immune modulation role in intracellular bacterial infection","volume":"14","author":"Duarte-Mata D.I.","year":"2023","unstructured":"Duarte-Mata D.I. and Salinas-Carmona M.C.: Antimicrobial peptides\u00b4 immune modulation role in intracellular bacterial infection. Front Immunol 2023; 14.","journal-title":"Front Immunol"},{"key":"e_1_3_4_54_2","doi-asserted-by":"crossref","DOI":"10.3390\/ph7050545","article-title":"Human antimicrobial peptides and proteins","volume":"7","author":"Wang G.","year":"2014","unstructured":"Wang G.: Human antimicrobial peptides and proteins. Pharmaceuticals 2014; 7.","journal-title":"Pharmaceuticals"},{"key":"e_1_3_4_55_2","first-page":"dkae128","article-title":"Metabolic pathways and antimicrobial peptide resistance in bacteria","author":"Elbediwi M.","year":"2024","unstructured":"Elbediwi M. and Rolff J.: Metabolic pathways and antimicrobial peptide resistance in bacteria. J Antimicrob Chemother 2024; : dkae128.","journal-title":"J Antimicrob Chemother"},{"key":"e_1_3_4_56_2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01198","article-title":"Expression and roles of antimicrobial peptides in innate defense of airway mucosa: potential implication in cystic fibrosis","volume":"11","author":"Geitani R.","year":"2020","unstructured":"Geitani R., Moubareck C.A., Xu Z., Karam Sarkis D. and Touqui L.: Expression and roles of antimicrobial peptides in innate defense of airway mucosa: potential implication in cystic fibrosis. Front Immunol 2020; 11.","journal-title":"Front Immunol"},{"key":"e_1_3_4_57_2","doi-asserted-by":"crossref","DOI":"10.1007\/s10989-018-9723-8","article-title":"Biological properties, current applications and potential therapeautic applications of brevinin peptide superfamily","volume":"25","author":"Zohrab F.","year":"2019","unstructured":"Zohrab F., Askarian S., Jalili A. and Kazemi Oskuee R.: Biological properties, current applications and potential therapeautic applications of brevinin peptide superfamily. Int J Pept Res Ther 2019; 25.","journal-title":"Int J Pept Res Ther"},{"key":"e_1_3_4_58_2","article-title":"A novel antimicrobial peptide found in Pelophylax nigromaculatus","volume":"20","author":"Lu C.","year":"2022","unstructured":"Lu C., Liu L., Ma C., Di L. and Chen T.: A novel antimicrobial peptide found in Pelophylax nigromaculatus. J Genet Eng Biotechnol 2022; 20.","journal-title":"J Genet Eng Biotechnol"},{"key":"e_1_3_4_59_2","article-title":"Modification targeting the \u201cRana Box\u201d motif of a novel nigrocin peptide from Hylarana latouchii enhances and broadens its potency against multiple bacteria","volume":"9","author":"Bao K.","year":"2018","unstructured":"Bao K., Yuan W., Ma C., Yu X., Wang L., Hong M. et al: Modification targeting the \u201cRana Box\u201d motif of a novel nigrocin peptide from Hylarana latouchii enhances and broadens its potency against multiple bacteria. Front Microbiol 2018; 9.","journal-title":"Front Microbiol"},{"key":"e_1_3_4_60_2","article-title":"Design, optimization, and nanotechnology of antimicrobial peptides: from exploration to applications","volume":"39","author":"Tan P.","year":"2021","unstructured":"Tan P., Fu H. and Ma X.: Design, optimization, and nanotechnology of antimicrobial peptides: from exploration to applications. Nano Today 2021; 39.","journal-title":"Nano Today"},{"key":"e_1_3_4_61_2","doi-asserted-by":"crossref","DOI":"10.1007\/s13238-010-0004-3","article-title":"Alpha-helical cationic antimicrobial peptides: relationships of structure and function","volume":"1","author":"Huang Y.","year":"2010","unstructured":"Huang Y., Huang J. and Chen Y.: Alpha-helical cationic antimicrobial peptides: relationships of structure and function. Protein Cell 2010; 1.","journal-title":"Protein Cell"},{"key":"e_1_3_4_62_2","article-title":"Unlocking antibacterial potential: key-site-based regulation of antibacterial spectrum of peptides","volume":"67","author":"Wu W.","year":"2024","unstructured":"Wu W., Song J., Li T., Li W., Wang J., Wang S. et al: Unlocking antibacterial potential: key-site-based regulation of antibacterial spectrum of peptides. J Med Chem 2024; 67.","journal-title":"J Med Chem"},{"key":"e_1_3_4_63_2","article-title":"Effects of net charge and the number of positively charged residues on the biological activity of amphipathic \u03b1-helical cationic antimicrobial peptides","volume":"90","author":"Jiang Z.","year":"2008","unstructured":"Jiang Z., Vasil A.I., Hale J.D., Hancock R.E.W., Vasil M.L. and Hodges R.S.: Effects of net charge and the number of positively charged residues on the biological activity of amphipathic \u03b1-helical cationic antimicrobial peptides. Biopolym Pept Sci Sect 2008; 90.","journal-title":"Biopolym Pept Sci Sect"},{"key":"e_1_3_4_64_2","article-title":"Pyrazole derived ultra-short antimicrobial peptidomimetics with potent anti-biofilm activity","volume":"125","author":"Ahn M.","year":"2017","unstructured":"Ahn M., Gunasekaran P., Rajasekaran G., Kim E.Y., Lee S.J., Bang G. et al: Pyrazole derived ultra-short antimicrobial peptidomimetics with potent anti-biofilm activity. Eur J Med Chem 2017; 125.","journal-title":"Eur J Med Chem"},{"key":"e_1_3_4_65_2","doi-asserted-by":"crossref","DOI":"10.1002\/phar.2209","article-title":"International consensus guidelines for the optimal use of the polymyxins: endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)","volume":"39","author":"Tsuji B.T.","year":"2019","unstructured":"Tsuji B.T., Pogue J.M., Zavascki A.P., Paul M., Daikos G.L., Forrest A. et al: International consensus guidelines for the optimal use of the polymyxins: endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy 2019; 39.","journal-title":"Pharmacotherapy"},{"key":"e_1_3_4_66_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100954","article-title":"Antimicrobial peptides for combating drug-resistant bacterial infections","volume":"68","author":"Xuan J.","year":"2023","unstructured":"Xuan J., Feng W., Wang J., Wang R., Zhang B., Bo L. et al: Antimicrobial peptides for combating drug-resistant bacterial infections. Drug Resist Updates 2023; 68.","journal-title":"Drug Resist Updates"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037024002952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037024002952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2024.09.006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:52:29Z","timestamp":1781639549000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2024.09.006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":65,"alternative-id":["10.1016\/j.csbj.2024.09.006"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2024.09.006","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery, development and optimisation of a novel frog antimicrobial peptide with combined mode of action against drug-resistant bacteria","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2024.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}